Eloise Hudry
Company: NIBR
Job title: Associate Director, Preclinical Safety, Cell & Gene Therapy
Seminars:
Describing AAV-Driven Safety Findings (Depatotoxicity & Peripheral Neuropathy) in the Non-Human Primate & Potential Translatability 9:30 am
Outlining the future of preclinical development: Is in vivo modelling on the way out? Presentation of retrospectively analyzed data from preclinical non-human primate (NHP) studies to establish the time course of self-complementary AAV9(scAAV9)-related toxicology findings after systemic or intrathecal administration. Investigation of the potential triggers (capsid versus transgene) for such toxicities in the cynomolgus macaque, the…Read more
day: Conference Day Two